Skip to main content

Table 3 Factors associated with significant weight gain over 1 year after diagnosis of moderate-to-severe ulcerative colitis

From: Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea

Variable

Reference

Univariable analysis

Multivariable analysis

Odds Ratio

95% CI

P-value

Odds Ratio

95% CI

P-value

Lower

Upper

Lower

Upper

Age group (years) > 40

≤ 40

0.858

0.481

1.532

0.605

0.904

0.481

1.699

0.754

Female

Male

0.892

0.494

1.611

0.704

0.983

0.509

1.898

0.959

Disease extent at diagnosis

 Left-sided colitis

Proctitis

3.240

0.705

14.898

0.661

3.243

0.689

15.255

0.598

 Extensive colitis

7.085

1.545

32.494

0.002

6.502

1.363

31.022

0.006

Disease activity at diagnosisa

 Severe

Moderate

2.000

0.736

5.436

0.174

-

-

-

-

Weight loss at diagnosis = Yes

No

1.333

0.663

2.683

0.420

-

-

-

-

Smoking history at diagnosis

 Past

Never

0.756

0.404

1.414

0.120

-

-

-

-

 Current

1.753

0.624

4.927

0.170

-

-

-

-

EIMs at diagnosis = Yes

No

0.773

0.199

3.014

0.711

-

-

-

-

Disease activity at 1 year = Non-remissionb

Remission

0.368

0.194

0.697

0.002

0.492

0.227

1.069

0.073

Number of relapses during the 1 year

-

0.525

0.331

0.831

0.006

0.683

0.401

1.164

0.161

Initial systemic steroid use = Yes

No

1.503

0.840

2.688

0.170

-

-

-

-

Exposed medication during the 1 year

 Systemic steroid = Yes

No

1.343

0.726

2.484

0.348

-

-

-

-

 Immunomodulators = Yes

No

1.019

0.550

1.889

0.953

-

-

-

-

 Biologics = Yes

No

0.465

0.167

1.291

0.142

-

-

-

-

  1. CI confidence interval, EIMs extraintestinal manifestations
  2. aFull Mayo clinic score
  3. bPartial Mayo clinic score